| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Intensive Care Unit pavilion G, Edouard Herriot Hospital, Lyon, France
2 From the Department of Hepato-gastroenterology, Hotel-Dieu Hospital, Lyon, France
3 From the Department of Surgery and Liver Transplantation, Croix-Rousse Hospital, Lyon, France
Study objectives: Contrast transthoracic echocardiography (TTE) is currently used to identify intrapulmonary shunt (IPS) in patients with end-stage liver disease. The aim of this study was to compare the use of contrast TTE and transesophageal echocardiography (TEE) in detecting IPS.
Design: Thirty-seven consecutive outpatients with severe liver disease awaiting liver transplantation underwent contrast TEE and TTE. The IPS was assessed semiquantitatively in four grades with TEE and as positive or negative with TTE.
Setting: ICU.
Interventions: Patients underwent contrast TEE after pharyngeal anesthesia alone followed by contrast TTE. Contrast echocardiography was performed with a modified fluid gelatin solution.
Results: Overall detection rate of an IPS was 51% with TEE and 32% with TTE (p<0.001). Four patients had an IPS detected with TEE but not with TTE. Quality of imaging was poor in 22% with TTE and 0% with TEE (p<0.001). A PaO2 <80 mm Hg or a dyspnea was associated with an IPS in 56% and 50% of patients with TEE and in 33% and 25% with TTE, respectively.
Conclusion: Contrast-enhanced TEE is superior to TTE for detecting an IPS in patients with severe liver disease awaiting liver transplantation. The use of gelatin contrast solution allows an early detection of IPS. Recause of the high sensitivity of TEE, all patients suspected of hepatopulmonary syndrome should undergo TEE in search of an IPS if TTE is normal.
Key Words: hepatopulmonary syndrome • intrapulmonary shunt • liver transplantation • transesophageal echocardiography
Submitted on July 2, 1996
Accepted on November 11, 2007
This article has been cited by other articles:
|
|
 |
|
  R. Rodriguez-Roisin, M.J. Krowka, Ph. Herve, M.B. Fallon, and on behalf of the ERS Task Force Pulmonary-Hepatic Pulmonary-Hepatic vascular Disorders (PHD) Eur. Respir. J., November 1, 2004; 24(5): 861 - 880. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Cottin, H. Plauchu, J.-Y. Bayle, M. Barthelet, D. Revel, and J.-F. Cordier Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia Am. J. Respir. Crit. Care Med., May 1, 2004; 169(9): 994 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Schenk, V Fuhrmann, C Madl, G Funk, S Lehr, O Kandel, and C Muller Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences Gut, December 1, 2002; 51(6): 853 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Reilly, P. A. Tunick, R. J. Timmermans, B. Stein, B. P. Rosenzweig, and I. Kronzon Contrast echocardiography clarifies uninterpretable wall motion in intensive care unit patients J. Am. Coll. Cardiol., February 1, 2000; 35(2): 485 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. GOSSAGE and G. KANJ Pulmonary Arteriovenous Malformations . A State of the Art Review Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 643 - 661. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
